Table 2. Dietary intakes of the study participants at baseline and end of the intervention.

Variable		Intervention group (n = 35)	Placebo group (n = 35)	p value*
Energy (kcal/day)
	Baseline	1,902.0 ± 642.9	1,730.2 ± 548.2	0.23
	End	1,306.8 ± 376.6	1,264.3 ± 322.5	0.62
	p value†	0.00	0.00
Carbohydrate (g)
	Baseline	226.1 ± 79.1	226.4 ± 72.6	0.98
	End	153.2 ± 57.6	158.7 ± 39.1	0.65
	p value†	0.00	0.00
Protein (g)
	Baseline	74.0 ± 33.9	68.8 ± 20.6	0.45
	End	51.6 ± 21.6	47.2 ± 16.7	0.36
	p value†	0.001	0.00
Fat (g)
	Baseline	81.0 ± 38.7	67.9 ± 22.2	0.08
	End	55.6 ± 17.9	50.6 ± 21.1	0.32
	p value†	0.003	0.003
SFA (g)
	Baseline	18.5 ± 8.9	18.2 ± 6.1	0.86
	End	12.9 ± 5.8	9.6 ± 5.1	0.63
	p value†	0.00	0.005
MUFA (g)
	Baseline	23.9 ± 14.7	22.4 ± 8.3	0.61
	End	16.2 ± 7.3	13.5 ± 6.4	0.12
	p value†	0.00	0.005
PUFA (g)
	Baseline	28.6 ± 19.5	21.3 ± 9.4	0.06
	End	17.5 ± 9.8	14.5 ± 9.5	0.23
	p value†	0.013	0.004
Dietary fiber (g)
	Baseline	9.5 ± 4.1	11.8 ± 5.3	0.052
	End	6.3 ± 4.8	8.3 ± 3.9	0.069
	p value†	0.002	0.014
Vitamin A (µg)
	Baseline	1,937.6 ± 2,463.3	752.0 ± 597.0	0.011
	End	1,181.2 ± 1,992.9	1,417.7 ± 1,787.6	0.62
	p value†	0.28	0.028
Vitamin C (mg)
	Baseline	40.3 ± 36.3	49.8 ± 37.1	0.29
	End	30.5 ± 25.4	43.2 ± 26.4	0.06
	p value†	0.073	0.307
Vitamin E (mg)
	Baseline	32.7 ± 28.6	20.5 ± 12.3	0.025
	End	18.7 ± 14.1	16.9 ± 15.8	0.62
	p value†	0.017	0.115

Values are expressed as means ± standard deviation. Bold-faced p value < 0.05 was considered as significant.

SFA, saturated fatty acid; PUFA, polyunsaturated fatty acid; MUFA, monounsaturated fatty acid.

^*Independent t-test between the two groups at pre-and post-intervention; ^†Paired t-test.